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Abstract: Abdominal aortic aneurysm (AAA) is a focal dilatation of the aorta, caused by both genetic 17 
and environmental factors. Although vascular endothelium plays a key role in AAA progression, 18 
the biological mechanisms underlying the mechanical stress involvement are only partially 19 
understood. In this study, we developed an in vitro model to characterize the role of mechanical 20 
stress as a potential trigger of endothelial deregulation in terms of inflammatory response bridging 21 
between endothelial cells (ECs), inflammatory cells, and matrix remodeling. In AAA patients, data 22 
revealed different degrees of calcification, inversely correlated with wall stretching and also with 23 
inflammation and extracellular matrix degradation. In order to study the role of mechanical 24 
stimulation, endothelial cell line (EA.hy926) has been cultured in healthy (10% strain) and 25 
pathological (5% strain) dynamic conditions using a bioreactor. In presence of TNF-α, high levels of 26 
MMP-9 expression and inflammation are obtained, while mechanical stimulation significantly 27 
counteracts the TNF-α effects. Moreover, physiological deformation also plays a significant role in 28 
the control of the oxidative stress. Overall our findings indicate that, due to wall calcification, in 29 
AAA there is a significant change in terms of decreased wall stretching. 30 
Keywords: cardiovascular diseases; abdominal aortic aneurysm; oxidative stress; inflammation; 31 
calcification; cyclic stretch 32 
 33 
1. Introduction 34 
Abdominal aortic aneurysm (AAA) is a degenerative disease caused by permanent dilatation of 35 
the aorta in the abdominal infrarenal tract. [1] AAA annual incidence is 0.4%-0.67% in western 36 
population [2–4], while the prevalence is 4%-8% [5–7], and it is more common in men than in women. 37 
Although the exact aetiology of AAA is unknown, there are several risk factors related to AAA 38 
development such as male gender, age (≥ 50 years old), smoking habits, atherosclerosis and 39 
hypertension, and some genetic factors. [8,9] Aneurysm can develop slowly, even silently and 40 
asymptomatically until the rupture occurs, causing massive haemorrhage with an elevated risk of 41 
death due to hypovolemic and haemorrhagic shock. [10] Extracellular matrix (ECM) degradation and 42 
oxidative stress represent hallmarks of AAA progression. [11] Calcification is commonly found 43 
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within the aneurysm wall and leading to wall stiffening, and eventually to its rupture. [12] Moreover, 1 
increased mechanical stresses due to turbulent flow within the wall contribute to AAA progression 2 
and rupture. [13] The ability of a vascular wall to relax and passively contract depending on pressure 3 
changes and blood flow is a physiological characteristic of large elastic arteries, and it is defined as 4 
“compliance”. Bloodstream in the vascular compartment follows the laws of laminar flow; laminar 5 
flow is altered by the reduction of flow velocity (blood stasis) as well as by the fluctuation of flow 6 
(turbulence). The classical turbulent flow causes endothelial damage as it leads to the generation of 7 
flows that are contrary to the direction of the circulatory current, also generating pockets of stasis. 8 
[14] In arterial aneurysms, especially those with saccular morphology, there may be a slowing down 9 
of flow until blood stasis.  10 
Blood flow in the arterial aneurysm follows La Place's law, which explains how the parietal 11 
tension (T) depends on the transmural pressure (Ptm), the wall thickness (d) and the radius of the 12 
container (r) according to the equation:  13 
T= (Ptm*r)/d. 14 
If the volume increases, the parietal voltage increases. In fact, if the vessel expands, the increase 15 
in the radius coupled with the decrease in the wall thickness increases the tension required to 16 
counteract the transmural pressure. Blood vessels function as viscoelastic tubes and respond to a 17 
transmural pressure gradient as a function of blood vessel wall composition. As vessel wall is 18 
subjected to a transmural pressure gradient, a portion of the intraluminal energy is used to stretch 19 
the fibers within the wall. The energy stored within the blood vessel fibers is later released back into 20 
the system, upon closure of the aortic valve. As intraluminal pressure oscillates, the constant loading 21 
and unloading of the fibers in the vessel wall result in a change in diameter of the blood vessel, which 22 
is noted clinically as a palpable pulse. Although vascular ECs and vascular smooth muscle cells 23 
(vSMCs) are exposed to both types of mechanical forces, shear stress resulting from blood flow is 24 
sensed mainly by ECs [15], whereas both ECs and vSMCs are subjected to cyclic stretch resulting 25 
from pulsatile pressure. In pathological remodeling, ECs can be influenced on structural as well as 26 
functional aspects. Firstly, they can change morphology, acquiring a bigger size and an irregular 27 
shape; they can also lose most of their regulatory roles. Endothelial layer can become more 28 
permeable, allowing the transit of several substances and vSMC infiltration. Endothelium shows 29 
inflammatory features, and it is characterized by the hyperexpression of proinflammatory cytokines 30 
(IL-1, IL-6, TNF-α), proinflammatory chemokines (IL-8, MCP-1, and regulated upon activation, 31 
normal T-Cell expressed- and secreted- RANTES) [16,17] and cell adhesion molecules (CAMs) such 32 
as selectins and integrins, [18]  with a significant production of reactive oxygen species (ROS), in 33 
particular hydrogen peroxide (H2O2), superoxide (O2-), and hydroxyl radical (.OH). [19,20] 34 
Deregulation of NADPH oxidase (NOX), xanthine oxidase (XO), superoxide dismutase (SOD), 35 
thioredoxin (TRX), and catalase results in extreme ROS production. [21,22] Moreover, ROS regulate 36 
ECM remodeling, acting directly on matrix metalloproteinases (MMPs) up-regulation, activating 37 
nuclear factor kB (NF-kB) and activator protein (AP-1). [23–25] The aim of this work is to clarify the 38 
role of vascular wall stretching in the maintenance of vascular physiology reproducing in vitro the 39 
pathological dilatation (static and 5%), due to calcification, and physiological (10%) cyclic (1 Hz) 40 
stretch of the vessel wall, in order to study the effects of mechanical stress on ECs functionality in 41 
terms of inflammation, matrix remodeling, and oxidative stress production.  42 
2. Results 43 
2.1. Relationship between wall stress and degree of calcification 44 
Patient-specific AAA geometries are reconstructed, and structural analysis is performed to 45 
calculate the wall stresses of the AAA models and their calcification. In figure 1A is shown how the 46 
wall dilatation changes in relation to the amount of calcification. Retrospective analyses of literature 47 
show that the aortic dilatation in healthy donors is 10% considering the ratio between systole and 48 
diastole; this data is confirmed also by our measures on healthy controls. In fact, in presence of 49 
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aneurysm the dilatation is less than 10%, and it decreases when the calcification index increase 1 
(Figure 1A). Control aortas and AAA sections are stained with Von Kossa to confirm the calcification 2 
degrees obtained by the measurements with computed axial tomography (CAT) analysis. As 3 
expected, controls do not show any calcium accumulation, while AAA tissues present dark spots 4 
(calcium deposition) in particular in the medial layer, in a directly proportional manner to the degree 5 
of calcification, as shown by related quantification (Figure 1B and 1C).  6 
 7 
Figure 1. Wall stress and calcification correlation, (a) Graph showing the relation between AAA 8 
dilatation and calcification (AAC, aortic aneurysm calcification); (b) Representative images of 9 
calcification degree evaluated by Von Kossa staining in paraffin-embedded tissues. Scale bar 200    10 
µm; (c) Quantification of calcium content in healthy tissues (CTRL) and aneurysm tissues evaluated 11 
by ImageJ software. * indicates p ≤ 0.05 respect to control. 12 
2.2. Correlation between calcium deposition and inflammation 13 
Knowing that AAA is characterized by an inflammatory condition, different inflammatory 14 
markers related to inflammatory cells are investigated, in particular CD4, CD20, and CD68, 15 
respectively for T-helper lymphocyte, B-cell, and macrophage identification.  Control tissues are 16 
negative for all the markers, while in the low and medium AAC index all these markers are 17 
significantly represented. High AAC index tissues show a decrease of the inflammatory population 18 
correlated to CD4, CD20, and CD68 markers with respect to low and medium indexes. (Figure 2).  19 
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 1 
Figure 2. Inflammatory cell infiltration in AAA. Representative immunohistochemistry for anti CD4, 2 
CD8, CD68 staining. CD4+ is performed for T-helper lymphocytes, CD8+ for T-killer, and CD68 for 3 
monocytes-macrophage. Healthy aorta, represented on the left, is negative for inflammatory cells 4 
infiltration. Scale bar 200 µm. 5 
Other pro-inflammatory and calcification markers were investigated on tissue lysate, such as 6 
MMP-9, IL-6 and osteopontin (Figure 3A and 3B). For all the considered markers, we obtain a 7 
significant difference between patients and controls. Differences related to the degree of calcification 8 
are appreciable: considering MMP-9, samples with medium index of calcification reach the higher 9 
expression as observed by western blot assay as well as the higher proteolytic activity, as indicated 10 
by zymography assay.  The high calcification index indicates also the terminal phase of the 11 
degradation, thus MMP-9 results decreased in terms of protein expression and proteolytic activity. 12 
Considering IL-6 as an inflammatory marker, it decreases with the progression of calcium 13 
accumulation confirming the previous data, particularly, it has the same trend as MMP-9. As 14 
expected, patients with high calcification index have an increased expression of OPN, which has an 15 
osteogenic activity (Figure 3B). No significant differences are observed between healthy donors and 16 
patients in all AAC indices for MMP-2 activity (Figure 3A) 17 
  18 
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 1 
Figure 3. Matrix remodeling, inflammation and calcification in AAA tissues. (a) Gelatin zymography 2 
performed on tissue lysates of patients with different degree of calcification and the respective 3 
quantification of MMP-2 and MMP-9 activity; (b) Immunoblot on MMP-9, Il-6, and Osteopontin 4 
(OPN) on tissue lysates of patients with different degree of calcification. The graph shows the relative 5 
quantification. * statistically significant with respect to control p<0,05. 6 
2.3. Oxidative stress proteins are overexpressed in AAA 7 
The proteomic analysis of aortic abdominal aneurysms and control healthy vessel tissues was 8 
performed with LC-MS in order to investigate the modulation of some proteins related to the 9 
oxidative stress processes. Table 1 reports the identities, the modulation and the biological functions 10 
of seven proteins resulted over expressed in the AAA respect with the healthy tissues. The 11 
enrichment of all these proteins indicates that the oxidative stress pathway is strongly involved in 12 
the AAA disease and that is particularly upregulated in the aortic abdominal vessel tissue.  13 
Catalase (CATA) and Superoxide dismutase [Mn], mitochondrial (SODM) presented a fold 14 
change of 2.51 and 6.95 respectively: these two proteins are involved in the cellular response to 15 
oxidative stress pathway, as a result of the exposure to high levels of reactive oxygen species. SODM 16 
is also involved in the removal of superoxide radicals and in oxidation-reduction processes. 17 
Regarding the last biological function, we found that Protein disulfide-isomerase (PDIA1), Isoform 18 
H14 of Myeloperoxidase (PERM), Ceruloplasmin (CERU), Ferritin heavy chain (FRIH), and Ferritin 19 
light chain (FRIL) were all strongly upregulted (fold chnge of 2.50, 3.04, 12.83, 21.83 and 26.43) in the 20 
AAA tissue. 21 
  22 
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Table 1. Proteomic analyses results. 1 
PROTEIN 
ACCESSION 
NAME 
FOLD CHANGE 
(p-value < 0.05) 
AAA/Healthy 
BIOLOGICAL 
FUNCTION 
Protein disulfide-
isomerase 
PDIA1_HUMAN 2,50 oxidation-reduction process 
Isoform H14 of 
Myeloperoxidase 
PERM_HUMAN 3,04 oxidation-reduction process 
Superoxide dismutase 
[Mn], mitochondrial 
SODM_HUMAN 6,95 
cell response to oxidative stress, oxidation-
reduction process, removal of superoxide 
radicals 
Ceruloplasmin CERU_HUMAN 12,83 oxidation-reduction process 
Ferritin heavy chain FRIH_HUMAN 21,83 oxidation-reduction process 
Ferritin light chain FRIL_HUMAN 26,43 oxidation-reduction process 
Catalase CATA_HUMAN 2,51 cell response to oxidative stress 
Table 1. Upregulated proteins in AAA vessel tissue after comparison to healthy tissues by proteomic 2 
analysis. The upregulated proteins were selected using p value < 0.05. 3 
A protein-protein interaction analysis (Figure 4) of oxidative stress-related proteins was 4 
performed using STRING. The network analysis showed a high-connected network among these 5 
proteins. Ferritin light chain and Ferritin heavy chain are co-expressed, showed evidence in 6 
experimental and association in curated database. Also Superoxide dismutase, Catalase and Protein 7 
disulfide-isomerase showed the same connections. The other linked proteins mainly showed text-8 
mining evidence. 9 
 10 
Figure 4. STRING network analysis of oxidative stress-related proteins that are over expressed in 11 
AAA vessel tissue respect with normal tissue. A proteome interactomic map was performed using 12 
the STRING tool for obtaining cross correlation information. Homo sapiens was selected as a reference 13 
organism. Different colored lines represent the existence of different types of evidence. A yellow line 14 
indicates text-mining evidence; a purple line, experimental evidence, a cyan line indicates association 15 
in curated database and black lines indicates co-expression data. 16 
2.3. Mechanical stimulation drives ROS/Superoxide production in EA.hy926 17 
Since mechanical stimulation seems to play a key role in driving the inflammatory response and 18 
matrix remodeling, an in vitro dynamic model with physiological and pathological strain parameters, 19 
culturing an endothelial cell line (EA.hy 926), was used. The effect of mechanical stimulation (5-10% 20 
deformation, 1 Hz frequency) is evaluated in the presence and the absence of an inflammatory 21 
stimulus (TNF-α 50 ng/ml) after three days of culture. Figure 5A shows cell morphology when 5% 22 
and 10% mechanical strain is applied for 3 days. While no differences were detected in terms of cell 23 
viability among the samples, 10% strain cultured cells display an elongated and oriented shape in the 24 
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strain direction, whereas random orientation is observed in the other samples (static and 5% strain). 1 
In terms of ROS/RNS production, the difference between 10% strained cells (physiological) and 5% 2 
strained or static cells (pathological) is confirmed, with lower ROS/RNS production in physiological 3 
conditions (Figure 5B and 5C).  4 
 5 
Figure 5. Mechanical strain drives ROS/RNS production. (a) EA.hy926 after 3 days of 5% and 10% 6 
strain. Phalloidin was used to observe cell morphology; (b) FACS analyses for ROS and RNS 7 
production. Dark red represents unstained cells, while light red represents the experimental samples. 8 
BL2-A for superoxide detection; BL1-A for ROS detection. (c) graph of ROS/RNS production * 9 
statistically significant with respect to static samples. p<0,05. 10 
2.4. Strain affects CD62E expression and monocytes adhesion 11 
As leukocytes adhesion on endothelium is promoted by CD62E expression on ECs membrane, 12 
we evaluated the effect of mechanical stress on CD62E as well (Figure 6A). As expected, E-selectin is 13 
upregulated in presence of TNF-α. Data show that the substrate deformation, both 5% and 10% 14 
stretching at 1Hz, significantly and proportionally counteracts TNF-α effects on CD62E expression 15 
(Figure 6A). In addition, data concerning monocytes adhesion nicely confirm these data. In fact, as 16 
shown in Figure 6B, the mechanical deformation, at both 5% and 10% at 1Hz, significantly inhibits 17 
the monocytes’ adhesion, also in presence of TNF-α.  18 
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 1 
Figure 6. Strain affect inflammation mediated by ECs (a) Representative immunofluorescence 2 
staining for CD62E after mechanical (5 and 10%) and chemical (TNF-α 50ng/mL) stimulation. CD62E 3 
is observed in red while DAPI is used for nuclear staining. Quantification of positive cells expressing 4 
CD62E. Normalization of samples stimulated by TNF-α in relation to the respective control. Scale Bar 5 
30 µm * p ≤ 0.05; (b) PBMCs adhesion on endothelial cells. PBMCs are observed in green. 6 
Normalization of samples stimulated by TNF-α in relation to the respective control (static, 5% and 7 
10%). Scale Bar 25 µm * p ≤ 0.05. 8 
2.5. Strain affects MMP-9 expression and activity in ECs. 9 
In static conditions, MMP-9 expression results strongly upregulated in presence of TNF-α. 10 
Applying a 5% substrate deformation, no significant inhibition of TNF-α effects is shown, resulting 11 
in an unmodified MMP-9 modulation (Figure 7), while no differences are found in absence of TNF-α 12 
with respect to static conditions. When a 10% substrate deformation is applied, MMP-9 expression 13 
results significantly downregulated in all conditions both in the absence and in the presence of TNF-14 
α.  15 
  16 
Figure 7. Strain affect MMP-9 expression and activity (a) Representative zymography assay to detect 17 
MMP-9 activity and expression after mechanical (5 and 10%) and chemical (TNF-α 50ng/mL) 18 
stimulation. Tubulin is used for loading control. 19 
  20 
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3. Discussion 1 
AAA is characterized by dramatic modifications of the medial layer, and it displays altered 2 
mechanical behavior, inflammatory response, and matrix remodeling in the aortic wall. [26] The 3 
calcification process has been acknowledged as a degenerative factor in inflammatory arterial 4 
diseases. Calcium deposits show a reverse correlation with aortic dilatation and inflammatory cell 5 
recruitment, as observed in our clinical data (results summarized in table 2). However, the specific 6 
role of aortic dilatation in AAA progression is not completely elucidated. Taking together the results 7 
on AAA patients, it is evident that the decrease in dilatation is related to the presence of vascular 8 
calcifications in the medial layer. Moreover, the presence of calcification affects MMP-9-promoted 9 
matrix remodeling. The severity of calcium deposition influences also IL-6-promoted inflammation, 10 
because in patients with high AAC index, most of cells, including also the inflammatory ones, are 11 
depleted and replaced by bone-like formation, resulting in a very low inflammatory infiltrate. Indeed, 12 
the higher levels of inflammation and matrix remodeling are found in patients with medium 13 
calcification index.  14 
Inflammatory cell recruitment in AAA is sustained by the presence of inflammatory mediators 15 
and by the increased expression of adhesion molecules able to interact with circulating inflammatory 16 
cells. [27] Specifically, inflammatory cells infiltrate in the media and adventitia layers, inducing 17 
oxidative stress and over expression of cytokines/chemokines and MMPs. The findings obtained by 18 
proteomic analyses unveil also the involvement of oxidative stress in AAA patients, underlined by 19 
the over expression of the proteins implied in oxidation-reduction process and in cell response to 20 
oxidative stress. All these processes lead to elastic fiber breakdown, and depletion of vSMCs. As a 21 
result, the aortic wall is weakened because of decreased thickness and reduced mechanical function. 22 
The aortic wall cannot counteract the blood flow and pressure, and the aortic wall dilates to form 23 
AAA. Among the inflammatory mediators, TNF-α plays a pivotal role in the initiation and 24 
progression of vascular disorder by modulating the expression of molecules involved in vascular 25 
tone, inflammation and remodeling, thus inducing endothelial dysfunction [28,29] and upregulating 26 
the adhesion molecules, such as CD62E. An inflammatory condition, which leads to endothelial 27 
dysfunction, contributes to the pathogenesis of vascular syndromes by predisposing vessels to plaque 28 
rupture and intravascular thrombosis. [30] Due to endothelial dysfunctions, thus, ECs also contribute 29 
to AAA progression. [31]  30 
In our study, we have tested two different percentages of substrate deformation on endothelial 31 
cell culture: 5% and 10% for 3 days at 1 Hz constant frequency, representing the resting heartbeat, 32 
while the substrate deformation of 10% is selected to mimic the dilation of the aortic wall under 33 
physiological conditions. [32] Our experimental settings are consistent with clinical findings on 34 
healthy individuals and on AAA patients with medium calcification index. (table 2) 35 
The results suggest that 10% stimulation controls inflammation and ROS/RNS production 36 
compared to 5% dynamic and static samples; moreover, this experimental condition significantly 37 
contrasts TNF-α-mediated inflammatory effects. Thus, these observations highlight the importance 38 
of physiological vascular wall stretching as a powerful anti-inflammatory stimulus. Indeed, a 39 
downregulation of MMP-9, CD62E, and a decrease of PBMC adhesion in 10% dynamic samples is 40 
observed. In TNF-α-stimulated static samples, MMP-9, CD62E and PBMC adhesion increase, 41 
demonstrating that these markers are closely related to the chronic inflammation. Overall, our 42 
findings indicate the importance of physiological vascular wall stretching as a powerful anti-43 
inflammatory stimulus able to inhibit the pathological progression of AAA. 44 
  45 
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Table 2. Summary of obtained data. 1 
 Low AAC index Medium AAC index High AAC index 
calcium deposits + ++ +++ 
dilatation (%) 5 < X < 10 ≃ 5 X < 5 
inflammation moderate high low 
ECM remodeling moderate high moderate 
Table 2 shows the results obtained on AAA tissue in terms of calcium accumulation, dilatation, 2 
inflammation value, and matrix remodeling. 3 
4. Materials and Methods  4 
4.1. Patients and healthy donors’ enrollment  5 
Abdominal aortic aneurysm tissues were provided by the Vascular Surgery Unit, Hospital 6 
Maggiore, Novara (Italy). AAA tissues were collected from 13 patients (100% male) subjected to open 7 
surgical repair (OSR); demographical and clinical data are reported in Table 3. All data and samples 8 
were collected from donors correctly informed for the use of excessive pathological material for 9 
diagnostic and research purpose according to the local institute’s regulation and policies based on 10 
Declaration of Helsinki (AVATAR, 1.0 – protocol 208/CE – CE 43/18). Peripheral blood from healthy 11 
donors was collected from AVIS Novara in order to isolate PBMC’s (AVATAR, 1.0 – protocol 208/CE 12 
– CE 43/18). 13 
4.2. AAA patients: calcification modelling and wall dilatation 14 
Calcificated regions are captured after the CAT exam. The amount of calcification was evaluated 15 
through a score (aortic aneurysm calcification-AAC- from 0 to 8): AAC 0-1 are considered low 16 
calcification index, AAC 2-3-4 are medium index, and AAC 5-6 high index [13]. Geometries of AAAs 17 
are reconstructed, and images of the abdominal aorta are obtained from immediately distal to the 18 
renal arteries to immediately proximal to the iliac bifurcation during doppler ultrasound 19 
examination. Maximum AAA diameter, determined by B-MODE doppler ultrasound, is 72 mm. The 20 
values of aneurysm dilatation are obtained using the following formula: 21 
𝑨𝒐𝒓𝒕𝒊𝒄 𝒏𝒆𝒄𝒌 𝒔𝒚𝒔𝒕𝒐𝒍𝒆 − 𝒂𝒐𝒓𝒕𝒊𝒄 𝒏𝒆𝒄𝒌 𝒅𝒊𝒂𝒔𝒕𝒐𝒍𝒆
𝒂𝒐𝒓𝒕𝒊𝒄 𝒏𝒆𝒄𝒌 𝒅𝒊𝒂𝒔𝒕𝒐𝒍𝒆
: 
𝒂𝒏𝒆𝒖𝒓𝒚𝒔𝒎 𝒔𝒚𝒔𝒕𝒐𝒍𝒆 − 𝒂𝒏𝒆𝒖𝒓𝒚𝒔𝒎 𝒅𝒊𝒂𝒔𝒕𝒐𝒍𝒆
𝒂𝒏𝒆𝒖𝒓𝒚𝒔𝒎 𝒅𝒊𝒂𝒔𝒕𝒐𝒍𝒆
= 𝟎. 𝟏: 𝒙 22 
Differences between systole and diastole of the aortic neck (healthy part) and the aneurysm are 23 
normalized with their respective diastole. The proportion is obtained comparing the differences with 24 
10% that is the physiological measured dilatation of the healthy aorta. 25 
  26 
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Table 3. Demographical and clinical feature of AAA patients. 1 
Patients 
Age 
mean±S
D 
Gende
r 
DAAA 
mean±S
D 
Hypercholesterolem
ia 
Smoking Hypertension 
Ischemic 
cardiomyopath
y 
Low 
AAC 
72±4 
Male 
100% 
5.6±1.4 100% 33% 100% 66% 
Medium 
AAC 
75±6 
Male 
100% 
5.4±1.3 50% 50% 88% 50% 
High 
AAC 
71±12 
Male 
100% 
5.3±0.6 100% 33% 100% 66% 
Table 3 shows demographical data (age, sex) and cardiovascular risk (DAAA aneurysm diameters, 2 
hypercholesterolemia, smoking, hypertension, and ischemic cardiomyopathy). Age and DAAA are 3 
represented as mean ± standard deviation. Patient data are divided by the grade of aortic calcification 4 
index (AAC). 5 
4.3. Histological analyses on human aortic samples 6 
AAA and control samples were fixed in neutral buffered formalin for 24 hours, and 5 µm-thick 7 
sections were cut from paraffin-embedded tissues. Briefly, rehydrated sections were treated with a 8 
1% aqueous silver nitrate solution (Sigma Aldrich, Italy). Silver is deposited replacing the calcium 9 
reduced by the strong light, and thereby visualized as metallic silver. To counterstain the samples 10 
was also used a 5% sodium thiosulfate solution and 0.1% nuclear fast red solution. Calcium deposits 11 
and salts are detectable in black or brown-black, nuclei in red and cytoplasm in pink. All images were 12 
acquired using Pannoramic MIDI 3DHISTECH and analyzed with Pannoramic Viewer software 13 
(3DHISTECH, Hungary). For objective quantification of calcium content ImageJ software was used. 14 
4.4. Proteomic analysis 15 
Tissues obtained from AAA vessel and from healthy control vessel were lysed in RIPA buffer 16 
(150 mM sodium chloride, 1% Triton X100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 17 
1 mM EDTA, 1 mM EGTA, 50 mM TRIS pH = 7.4) supplemented with protease inhibitors (0.2 mM 18 
sodium othovanadate, 1 mM phenylmethyl sulfonyl fluoride and protease inhibitors cocktail, all 19 
from Sigma, Italy). Proteins concentration was determined using the bicinchoninic acid assay (Pierce, 20 
Rockford, IL, USA). Lysate proteins were digested using the following protocol: samples were 21 
subjected to denaturation with TFE, to reduction with DTT 200 mM, alkylation with IAM 200 mM 22 
and the complete protein trypsin digestion with 2 µg of Trypsin/Lys-C (Promega, Madison, WI, 23 
USA). The peptide digests were desalted on the Discovery®  DSC-18 solid phase extraction (SPE) 96-24 
well Plate (25 mg/well) (Sigma-Aldrich Inc., St. Louis, MO, USA). Peptides were dried by Speed 25 
Vacuum until the analysis.  26 
LC–MS/MS analyses were performed on digests using a micro-LC Eksigent Technologies 27 
(Dublin, USA) system with a stationary phase of a Halo Fused C18 column (0.5 × 100 mm, 2.7 µm; 28 
Eksigent Technologies, Dublin, USA). The injection volume was 4.0 µL and the oven temperature 29 
was set at 40 °C. The mobile phase was a mixture of 0.1% (v/v) formic acid in water (A) and 0.1% 30 
(v/v) formic acid in acetonitrile (B), eluting at a flow-rate of 15.0 µL min− 1 at an increasing 31 
concentration of solvent B from 2% to 40% in 30 min. LC system was interfaced with a 5600 + 32 
TripleTOF system (AB Sciex, Concord, Canada) equipped with a DuoSpray Ion Source and CDS 33 
(Calibrant Delivery System). The relative abundance of proteins was obtained using the label-free 34 
quantification. Samples were subjected to data-dependent acquisition (DDA): the mass spectrometer 35 
analysis was performed using a mass range of 100–1500 Da (TOF scan with an accumulation time of 36 
0.25 s), followed by a MS/MS product ion scan from 200 to 1250 Da (accumulation time of 5.0 ms) 37 
with the abundance threshold set at 30 cps (35 candidate ions can be monitored during every cycle). 38 
The samples were, then, subjected to cyclic data independent analysis (DIA) of the mass spectra, 39 
using a 25-Da window: the mass spectrometer was operated such that a 50-ms survey scan (TOF-MS) 40 
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was performed and subsequent MS/MS experiments were performed on all precursors.20,21 The MS 1 
data were acquired with Analyst TF 1.7 (AB SCIEX, Concord, Canada). Three instrumental replicates 2 
for each sample were subjected to the DIA analysis.  3 
Protein identification was performed using Mascot v. 2.4 (Matrix Science Inc., Boston, USA), the 4 
digestion enzyme selected was trypsin, with 2 missed cleavages and a search tolerance of 50 ppm 5 
was specified for the peptide mass tolerance, and 0.1 Da for the MS/MS tolerance. The charges of the 6 
peptides to search for were set to 2 +, 3 + and 4 +, and the search was set on monoisotopic mass. The 7 
instrument was set to ESI-QUAD-TOF and the following modifications were specified for the search: 8 
carbamidomethyl cysteines as fixed modification and oxidized methionine as variable modification. 9 
The UniProt Swiss-Prot reviewed database containing human proteins (version 2015.07.07, 10 
containing 42131 sequence entries) was used and a target-decoy database search was performed. 11 
False Discovery Rate was fixed at 1%. The label-free quantification was carried out with PeakView 12 
2.0 and MarkerView 1.2. (ABSCIEX, Concord, Canada). The up-regulated proteins were selected 13 
using P value < 0.05 and fold change >1.5. The up-regulated proteins were analyzed by using STRING 14 
software (http://string-db.org), which is a database of known and predicted protein-protein 15 
interactions. 16 
4.5. Dynamic cell culture 17 
Human endothelial cells, EA.hy926 (ATCC®  CRL-2922™) were cultured in high-glucose 18 
Dulbecco’s modified Eagle’s medium (DMEM) enriched with 10% fetal bovine serum and penicillin 19 
(100 U/mL), streptomycin (100 µg/mL), and 2 mM glutamine mixture (all from Euroclone, Italy) at 20 
37°C in humid 5% CO2 atmosphere. Rectangular silicone pieces (3cm x 1.5cm) were cut and sterilized 21 
together with the culture chambers of the TC-3 bioreactor (Ebers Medical, Zaragoza, Spain). To 22 
facilitate cell adhesion to the silicone substrate (both static controls and dynamic samples) a type I 23 
collagen (50 µg/ml) coating was used. After 1 hour, the coating has been rinsed with sterile water to 24 
remove the exceeding collagen. Finally, Ea.hy926 (2*104 /cm2) were seeded, and after 24 hours 25 
(required for an optimal adhesion to the substrate), mechanical stimulation has been applied to the 26 
cell culture. A stretching of 5 and 10% was maintained for 72 hours, 50ng/mL of TNF-α (Sigma 27 
Aldrich, Italy) was added when required. Silicone controls were maintained under static conditions. 28 
4.6. Phalloidin staining 29 
Cells were fixed in formalin 4% and incubated with phalloidin TRITC (Sigma Aldrich, Italy) for 30 
45’ at 37°C. DAPI (Sigma Aldrich, Italy) was used for nuclear staining. Samples were observed at 31 
fluorescent microscope (DM2500 Leica, Germany). 32 
4.7. Cellular ROS/Superoxide Detection Assay kit 33 
Oxidative stress production was investigated through Cellular ROS/Superoxide detection assay 34 
kit (ab139476, Abcam, Italy) following the manufacturer’s protocol. Briefly, detached cells (static 35 
controls, 5%, and 10% of mechanical stimulation) were stained with oxidative stress reagent orange 36 
and green, then flow cytometry analyses were performed (ATTUNE NxT Cytometer, Invitrogen) and 37 
analysed by ATTUNE NxT flow cytometer software. Pyocyanin treated cells (400µM) were used as 38 
positive control.  39 
4.8. Immunofluorescence  40 
Immunofluorescence analyses were carried out on mechanically stimulated silicone cells and on 41 
static controls. 1*104 EA.hy926/cm2 were seeded and maintained in culture according to experimental 42 
protocols. After 3 days of stimulation, samples were fixed for 1 hour with 4% formalin. Samples were 43 
blocked for 1 hour with a 5% goat solution and 0.3% TRITON X-100 in PBS 1X and, then, incubated 44 
with the primary antibody (1:50 anti-E-selectin, Santa Cruz Biotechnology, USA) for 1 hour at room 45 
temperature. E-selectin is detected by a secondary antibody TRITC-conjugated (Perkin-Elmer, Italy) 46 
and observed at fluorescent microscope (DM2500 Leica, Germany). The images were acquired using 47 
Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  13 of 16 
 
LAS software (Leica, Germany). Data are expressed as TNF-alpha-treated versus the respective 1 
untreated samples ratio.  2 
4.9. Leukocyte-endothelium adhesion assay 3 
Peripheral blood mononuclear cells (PBMCs) were isolated with Histopaque® -1077 (Sigma 4 
Aldrich, Italy) from peripheral blood obtained by healthy donors. PBMCs adhesion assay was 5 
performed using Cell Biolabs’ CytoSelectTM Leukocyte-endothelium Adhesion Assay (Cell Biolabs 6 
Inc, USA). After mechanical stimulations, PBMCs were labeled by the LeukoTrackerTM solution. 7 
Labeled PBMCs were then incubated with static and dynamic cells in presence or not of TNF-α 8 
(50ng/mL). After 1 h of incubation, nonadherent cells were removed by gently rinsing with PBS. 9 
Adherent cells were counted in three separate fields using an inverted fluorescence microscope 10 
(DM2500 Leica, Germany). Data are expressed as TNF-alpha-treated versus the respective untreated 11 
samples ratio.  12 
4.10. Western Blot  13 
Culture cells and tissues were lysed in RIPA buffer supplemented with protease inhibitors. 14 
Proteins concentration was determined using the bicinchoninic acid assay (Pierce, Rockford, IL, 15 
USA). 50µg total proteins in sample buffer (62.5 mM Tris-HCl, pH 6.8, 20% glycerol, 5% β-16 
mercaptoethanol, 0.5% bromophenol blue) were resolved to SDS-PAGE and transferred to a 17 
nitrocellulose membrane (Amersham Biosciences, Buckinghamshire, UK). Membranes were 18 
incubated overnight with IL-6, OPN (Abcam, UK), MMP-9, Tubulin (Millipore, Italy) antibodies at 19 
4°C. Proteins were revelated with secondary antibody-peroxidase conjugates (Perkin-Elmer, Italy). 20 
Protein bands were visualized using ECL (Perkin-Elmer, Western lightning PLUS-ECL, Italy) 21 
detection reagents in a chemosensitive visualizer (VersaDoc, BioRad, Italy). In order to check the 22 
loaded proteins concentration, red ponceau (Sigma Aldrich, Italy) staining was considered.  23 
4.11. Zymography assay  24 
Non-reduced protein samples were resolved by SDS-PAGE gels containing gelatin (0.2%, Sigma 25 
Aldrich, Italy). Briefly, after electrophoresis, gels were incubated with TRITON X-100 for 3 h at room 26 
temperature, and then incubated in a solution of CaCl2 (1 mM) and NaCl (15 mM), pH 7.4 overnight 27 
at 37°C. Subsequently, gels were fixed and then stained with Coomassie Blue. For objective 28 
quantification ImageJ software was used. 29 
4.12. Statistical analyses  30 
All experiments were performed in triplicate. All data are expressed as mean values ± standard 31 
deviation. Using Student's t-test, the p-value is calculated and the differences between variables with 32 
a value of p <0.05 are considered statistically significant. 33 
5. Conclusions 34 
In conclusion, we found a negative correlation between calcium deposits and wall dilatation in 35 
presence of AAA. A decreased wall stretching, due to the presence of calcification, affects MMP-9-36 
mediated matrix degradation and IL-6-mediated inflammation. As expected, in vitro model on 37 
endothelial cell line shows that substrate deformation significantly regulates the inflammatory 38 
response and matrix remodeling.  39 
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Abbreviations 4 
AAA Abdominal Aortic Aneurysm 
ECs Endothelial cells 
TNF-α Tumor necrosis factor alpha 
MMP-9 Matrix metalloproteinase -9  
ECM Extracellular matrix 
PTM transmural pressure 
vSMCs Vascular smooth muscle cells 
IL-1 Interleukin-1 
IL-6 Interleukin-6 
IL-8 Interleukin-8 
MCP-1 Monocyte chemoattractant protein 1 
RANTES Regulated on activation, normal T cell expressed and secreted 
CAMs Cell adhesion molecules 
ROS Reactive oxygen species 
NADPH Nicotinamide adenine dinucleotide phosphate  
NOX Nicotinamide adenine dinucleotide phosphate oxidase 
XO Xanthine oxidase 
SOD Superoxide dismutase 
TRX Thioredoxin  
MMPs Matrix metalloproteinases 
NF-kB Nuclear factor kappa-light-chain-enhancer of activated B cells 
AP-1 Activator protein 1 
OPN Osteopontin 
CAT Computed axial tomography 
AAC Aortic aneurysm calcification 
RNS Reactive nitrogen species 
APOE Apoliprotein E 
OSR Open surgical repair 
DAAA Diameter of abdominal aortic aneurysm 
TFE Trifluoroethanol 
DTT Dithiothreitol 
IAM Iodoacetamide 
LC-MS/MS Liquid chromatography– tandem mass spectrometry 
CDS Calibrant Delivery System 
DDA Data-dependent acquisition 
TOF Time of flight 
DIA Data independent analysis 
DMEM Dulbecco’s modified Eagle’s medium 
TRITC Tetramethylrhodamine 
DAPI 4′,6-Diamidine-2′-phenylindole dihydrochloride 
RIPA Radioimmunoprecipitation buffer 
EDTA Ethylenediamenetetraacetic acid 
EGTA Ethyleneglycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
PBMCs Peripheral blood mononuclear cells 
PBS Phosphate Buffered Saline 
PBMCs    Peripheral blood mononuclear cells 
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